CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (NASDAQ: ATHX) introduced right now that Gil Van Bokkelen, Chairman and CEO, will current a company overview on the Financial institution of America Merrill Lynch 2020 Digital Healthcare Convention to traders and analysts. The presentation is scheduled for Thursday, Might 14, 2020 at 8:20 a.m. EDT.
Dr. Van Bokkelen will present a short overview of the Firm’s mission and its therapeutic platform, MultiStem® cell remedy. The presentation will embody data on the crucial care indications within the Firm’s progressing medical pipeline, together with the Part 2/three pivotal trial evaluating MultiStem cell remedy for the remedy of COVID-19 induced acute respiratory misery syndrome (ARDS) and its ongoing Part three trial of MultiStem cell remedy for the remedy of ischemic stroke. The Firm can even interact in digital conferences with different institutional representatives on the convention.
A reside webcast of the presentation might be accessed on the following hyperlink: http://www.veracast.com/webcasts/bofa/healthcare2020/id85592049.cfm or by visiting ‘Events & Presentations’ within the Traders Part on the Firm’s web site. An archived replay of the webcast will likely be obtainable one hour after the conclusion of the reside occasion on the Firm’s web site after the convention for a restricted time.
Athersys is a biotechnology firm engaged within the discovery and improvement of therapeutic product candidates designed to increase and improve the standard of human life. The Firm is creating its MultiStem® cell remedy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for illness indications within the neurological, inflammatory and immune, cardiovascular and different crucial care indications and has a number of ongoing medical trials evaluating this potential regenerative drugs product. Athersys has cast strategic partnerships and a broad community of collaborations to additional advance the MultiStem cell remedy towards commercialization. Extra data is offered at www.athersys.com. Comply with Athersys on Twitter at www.twitter.com/athersys.